Migdal Insurance & Financial Holdings’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
Migdal Insurance & Financial Holdings's BLUE Position: Q2 2021 in Review
Migdal Insurance & Financial Holdings sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 1,114 shares — an estimated $435K sold.
Migdal Insurance & Financial Holdings first reported a position in BLUE in Q4 2020 and held it in 2 quarters. The position peaked at $435K in Q1 2021. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.
- Migdal Insurance & Financial Holdings reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
- Migdal Insurance & Financial Holdings sold 1,114 bluebird bio shares in Q2 2021, an estimated $435K.
- Migdal Insurance & Financial Holdings first reported a position in bluebird bio in Q4 2020 and held it in 2 quarters.
- Migdal Insurance & Financial Holdings's bluebird bio position peaked at $435K in Q1 2021.
- 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.
Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.